Gonadal Hormone Regulation in Hypogonadotropic Syndromes

Hypogonadotropic syndromes arise from deficient hypothalamic gonadotropin-releasing hormone (GnRH) secretion or action, leading to impaired pituitary production of luteinising hormone (LH) and follicle-stimulating hormone (FSH) and consequently low sex steroid levels. In congenital hypogonadotropic hypogonadism (CHH) and Kallmann syndrome, disrupted GnRH neuron migration or function during embryonic development underpins pubertal failure, infertility and associated somatic features. Early life “mini-puberty” is pivotal for Sertoli cell proliferation and penile growth in males and for ovarian follicle maturation in females; its absence heralds long-term reproductive compromise. Genetic heterogeneity—encompassing protein-coding genes, guidance cues and non-coding RNAs—contributes to variable expressivity, oligogenic inheritance and partial recovery in some individuals. Advances in understanding the neurovascular interface of the median eminence, cell‐to‐cell signalling pathways and epigenetic regulators have begun to inform tailored hormone replacement strategies and potential molecular therapies. Early diagnosis and targeted intervention during the neonatal window can enhance fertility outcomes and improve life-long reproductive health.

Research from Nature Portfolio

Recent studies have uncovered a critical role for Semaphorin-6A in pubertal timing by regulating the neurovascular microenvironment of the median eminence. Oligodendrocyte-derived Semaphorin-6A, acting via the Plexin-A2 receptor, finely tunes vascular permeability adjacent to GnRH neuron terminals, ensuring appropriate hormone release. Disruption of this barrier impairs GnRH innervation and delays puberty onset. Identification of pathogenic SEMA6A variants in individuals with delayed puberty underscores the sensitivity of GnRH pulsatility to vascular cues and highlights Semaphorin-6A–Plexin-A2 signalling as a novel axis for therapeutic exploration in hypogonadotropic conditions.

Gonadal Hormone Regulation in Hypogonadotropic Syndromes publication trend

The graph below shows the total number of articles in gonadal hormone regulation in hypogonadotropic syndromes across all publications each year (not limited to Nature Index journals).

Technical terms

GnRH: Gonadotropin-releasing hormone secreted by hypothalamic neurons that stimulates pituitary LH and FSH release.

HPG axis: Hypothalamic–pituitary–gonadal axis, the endocrine feedback loop controlling reproductive hormone synthesis and action.

Mini-puberty: Transient activation of the HPG axis in infancy characterised by elevated gonadotropins and sex steroids crucial for early sexual organ development.

Semaphorin-6A: A neuronal guidance molecule produced by oligodendrocytes that influences GnRH neuron patterning and vascular permeability in the median eminence.

Notch signalling: A conserved cell-to-cell communication pathway, with ligands such as Jagged1, that regulates neuronal migration and differentiation.

References

1. Mini-Puberty, Physiological and Disordered: Consequences, and Potential for Therapeutic Replacement. Endocrine Reviews (2024).
2. SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability. Nature Communications (2023).
3. Defective Jagged1 signaling impacts GnRH development and contributes to congenital hypogonadotropic hypogonadism. JCI Insight (2023).
4. Deletion in RMST lncRNA impairs hypothalamic neuronal development in a human stem cell-based model of Kallmann Syndrome. Cell Death Discovery (2024).